首頁 > Patent analysis opinions

Article

Patent analysis opinions

VOYXACT Two-Year Data Released: IgA Nephropathy Treatment Advances Toward Kidney Function Preservation
release：2026/08/14

Sanofi's subcutaneous formulation of isatuximab has been approved by the FDA
release：2026/07/21

FDA Approves Gedatolisib, Bringing the First Pan-PI3K/mTOR Targeted Therapy to Patients with Advanced Breast Cancer
release：2026/07/21

The injectable paclitaxel (albumin-bound) (II) from CSPC Ouyi Pharmaceutical Ouyi Pharmaceutical has been approved for m
release：2026/06/22

Obinutuzumab Beta Approved for Primary Membranous Nephropathy
release：2026/06/22

The EU’s top court rules that Meta must compensate publishers for using news articles
release：2026/05/23

AbbVie’s CD20×CD3 bispecific antibody has been approved for marketing in China
release：2026/05/18

Sonrotoclax (BEQALZI™) Receives FDA Accelerated Approval
release：2026/05/18

Court Orders Retrial in Teva Pharmaceutical Industries’s Migraine Drug Patent Infringement Case Against Eli Lilly and Co
release：2026/04/24

Bayer’s blockbuster new lung cancer drug “Sevabertinib” has been approved for marketing in China
release：2026/04/24

Major Breakthrough in Pancreatic Cancer Treatment: Revolution Medicines Announces Phase III Results for Daraxonrasib
release：2026/04/24

Dolutegravir Sodium Tablets” from Aidea Pharma has been approved in China
release：2026/03/24

TOP